|
1
|
Scheff RJ and Schneider BJ: Non-small-cell
lung cancer: treatment of late stage disease: chemotherapeutics and
new frontiers. Semin Intervent Radiol. 30:191–198. 2013. View Article : Google Scholar :
|
|
2
|
Humphrey LL, Deffebach M, Pappas M,
Baumann C, Artis K, Mitchell JP, Zakher B, Fu R and Slatore CG:
Screening for lung cancer with low-dose computed tomography: a
systematic review to update the US Preventive services task force
recommendation. Ann Intern Med. 159:411–420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Becker N, Motsch E, Gross ML, et al:
Randomized study on early detection of lung cancer with MSCT in
Germany: study design and results of the first screening round. J
Cancer Res Clin Oncol. 138:1475–1486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Varela G and Thomas PA: Surgical
management of advanced non-small cell lung cancer. J Thorac Dis.
6(Suppl 2): S217–S223. 2014.PubMed/NCBI
|
|
6
|
Wrona A and Jassem J: The new TNM
classification in lung cancer. Pneumonol Alergol Pol. 78:407–417.
2010.(In Polish).
|
|
7
|
Ferketich AK, Niland JC, Mamet R, et al:
Smoking status and survival in the national comprehensive cancer
network non-small cell lung cancer cohort. Cancer. 119:847–853.
2013. View Article : Google Scholar
|
|
8
|
Tabutin M, Couraud S, Guibert B, et al:
Completion pneumonectomy in patients with cancer: postoperative
survival and mortality factors. J Thorac Oncol. 7:1556–1562. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen X, Gorlov P, Merriman KW, et al:
Association of smoking with tumor size at diagnosis in non-small
cell lung cancer. Lung Cancer. 74:378–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miron L, Bosanceanu M, Filimon R and
Petrariu FD: Clinical-epidemiological study on advanced non-small
cell lung cancer. Rev Med Chir Soc Med Nat Iasi. 118:492–496.
2014.PubMed/NCBI
|
|
11
|
Lei Y, Chen BJ, Zeng L and Li WM:
Application value of low-dose computed tomography for the screening
of lung cancer in high-risk group. Sichuan Da Xue Xue Bao Yi Xue
Ban. 43:584–587. 2012.(In Chinese). PubMed/NCBI
|
|
12
|
Wolf AS: Resection for subcentimeter
non-small cell lung cancer: outcomes for a Chinese population with
70% adenocarcinoma. J Surg Oncol. 110:225–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kadara H, Kabbout M and Wistuba II:
Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology.
17:50–65. 2012. View Article : Google Scholar
|
|
14
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gazdar AF and Thun MJ: Lung cancer, smoke
exposure, and sex. J Clin Oncol. 25:469–471. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yao X, Liu L, Zhang H, et al: Comparative
analysis of clinical features of lung cancer in west China hospital
in 2000 and 2010. Zhongguo Fei Ai Za Zhi. 15:355–360. 2012.(In
Chinese). PubMed/NCBI
|
|
17
|
Behera M, Owonikoko TK, Chen Z, et al:
Single agent maintenance therapy for advanced stage non-small cell
lung cancer: a meta-analysis. Lung Cancer. 77:331–338. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim YT, Seong YW, Jung YJ, et al: The
presence of mutations in epidermal growth factor receptor gene is
not a prognostic factor for long-term outcome after surgical
resection of non-small-cell lung cancer. J Thorac Oncol. 8:171–178.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
National Comprehensive Cancer Network.
NCCN Clinical Practice Guidelines in Oncology™. Non-Small Cell Lung
Cancer. 2:2012, http://www.tri-kobe.org/nccn/guideline/lung/english/non_small.pdf.
Accessed November 28, 2011
|
|
22
|
Non-Small Cell Lung Cancer Collaborative
Group. Chemotherapy and supportive care versus supportive care
alone for advanced non-small cell lung cancer. Cochrane Database
Syst Rev. CD0073092010.PubMed/NCBI
|
|
23
|
Shepherd FA, Dancey J, Ramlau R, et al:
Prospective randomized trial of docetaxel versus best supportive
care in patients with non-small-cell lung cancer previously treated
with platinum-based chemotherapy. J Clin Oncol. 18:2095–2103.
2000.PubMed/NCBI
|
|
24
|
Souquet PJ, Chauvin F, Boissel JP, et al:
Polychemotherapy in advanced non small cell lung cancer: a
meta-analysis. Lancet. 342:19–21. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hatzidaki D, Agelaki S, Mavroudis D, et
al: A retrospective analysis of second-line chemotherapy or best
supportive care in patients with advanced-stage non-small-cell lung
cancer. Clin Lung Cancer. 8:49–55. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salloum RG, Smith TJ, Jensen GA and Lafata
JE: Survival among non-small cell lung cancer patients with poor
performance status after first line chemotherapy. Lung Cancer.
77:545–549. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Horeweg N and de Koning H: The importance
of screening for lung cancer. Expert Rev Respir Med. 8:597–614.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jett JR: Current treatment of unresectable
lung cancer. Mayo Clin Proc. 68:603–611. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen VW, Ruiz BA, Hsieh MC, Wu XC, Ries LA
and Lewis DR: Analysis of stage and clinical/prognostic factors for
lung cancer from SEER registries: AJCC staging and collaborative
stage data collection system. Cancer. 120(Suppl 23): 3781–3792.
2014. View Article : Google Scholar : PubMed/NCBI
|
